Fundamental Research Analysts Give Zepp Health (NYSE:ZEPP) a $14.65 Price Target

Fundamental Research set a $14.65 target price on Zepp Health (NYSE:ZEPPFree Report) in a research note released on Tuesday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Zepp Health Price Performance

Zepp Health stock opened at $2.75 on Tuesday. The business has a 50 day simple moving average of $3.34 and a 200 day simple moving average of $2.99. Zepp Health has a one year low of $2.06 and a one year high of $8.40. The company has a market capitalization of $41.39 million, a PE ratio of -1.10 and a beta of 0.68. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.21 and a quick ratio of 0.87.

Institutional Trading of Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC purchased a new stake in shares of Zepp Health Co. (NYSE:ZEPPFree Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned approximately 0.09% of Zepp Health at the end of the most recent reporting period. Institutional investors own 52.61% of the company’s stock.

About Zepp Health

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Further Reading

Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.